Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to $60000.0.

  • MDxHealth's Shares Outstanding (Weighted Average) rose 50000.0% to $60000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $60000.0, marking a year-over-year increase of 50000.0%. This contributed to the annual value of $64000.0 for FY2024, which is 3333.33% up from last year.
  • MDxHealth's Shares Outstanding (Weighted Average) amounted to $60000.0 in Q3 2025, which was up 50000.0% from $64000.0 recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Shares Outstanding (Weighted Average) ranged from a high of $162.9 million in Q2 2022 and a low of $5000.0 during Q1 2022
  • For the 5-year period, MDxHealth's Shares Outstanding (Weighted Average) averaged around $26.3 million, with its median value being $48000.0 (2023).
  • As far as peak fluctuations go, MDxHealth's Shares Outstanding (Weighted Average) crashed by 9998.68% in 2022, and later surged by 10301944.58% in 2024.
  • Quarter analysis of 5 years shows MDxHealth's Shares Outstanding (Weighted Average) stood at $128.8 million in 2021, then tumbled by 99.99% to $17000.0 in 2022, then surged by 182.35% to $48000.0 in 2023, then surged by 103019.45% to $49.5 million in 2024, then crashed by 99.88% to $60000.0 in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $60000.0 for Q3 2025, versus $64000.0 for Q2 2025 and $39000.0 for Q1 2025.